el-GRen-US

 

Name of the medicinal product: FARLIPID

Content: 5ml oral emulsion contain 390mg Eicosapentaenoic acid (EPA) and 265mg Docosahexaenoic acid (DHA).

Pharmaceutical Form: Oral Emulsion

Pharmacotherapeutic group: Omega-3 poly-unsaturated fatty acids (EPA + DHA).

Packaging Description: Paper carton containing glass bottle of 300 ml of emulsion

FARLIPID contains omega3 fatty acids [Eicosapentaenoic acid (EPA) and Docosahexaenoic acid (DHA)]..
Indicated: Hypertriglyceridemia
For use in patients in whom it is desired to fall in plasma triglyceride. It must be used in conjunction with proper diet.
FARLIPID is concentrated fish oil with high content of essential polyunsaturated fatty acids of the series of omega-3 and in particular eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). The regular continuous intake of FARLIPID oral emu. in the diet leads to a prolonged decline in the level of triglycerides in the blood.
Contraindications: allergy to any of its ingredients. In asthmatic patients sensitive to aspirin.
Special warnings and precautions for use:
General:
Before taking your medicine, tell your doctor if you experience blood disorders such as hemophilia or if you are taking anticoagulants or other medications that affect blood clotting. There is evidence to suggest that products containing fish oil can cause bronchospasm crisis in asthmatic patients sensitive to aspirin. Doses of FARLIPID exceeding 5g / day may cause little deterioration in the control of glucose in non-insulin dependent diabetic patients. Use with caution in patients with diabetes mellitus type 2
Elderly: No special precautions.
Pregnancy:
There is no experience of using FARLIPID during pregnancy and that why its use is contraindicated in this situation.
Lactation:
There is no experience of using FARLIPID during lactation, so its use is contraindicated in this situation.
Children: The use of FARLIPID oral emu, has not been established in children.
Effects on ability to drive and use machines:
There no seems to affect.
Interactions with other drugs or substances:
Before taking your medicine, tell your doctor if you are taking other medicines, including those bought without a prescription. Especially, tell your doctor if you are taking anticoagulants or other medications that affect blood clotting, such as aspirin, cephalosporins.
Overdose - Control:
FARLIPID comprised entirely of components included in a normal diet and is considered harmless in the recommended dosage. Deleterious effects due to overdose are unlikely to occur.


The frequencies of adverse events are ranked according to the following:
Common (> 1/100), Uncommon (> 1/1000, <1/100) Rare (> 1/10000, <1/1000), Very rare (<1/10000), including isolated reports.
Infections and infestations: Uncommon: Gastroenteritis
Immune system disorders: Uncommon: Ypefefaisthisia
Metabolism and nutrition disorders: Rare: Hyperglycaemia
Nervous System Disorders: Uncommon: Dizziness, dysgeusia Rare: headache
Vascular System: Very rare: Hypotension
Respiratory System, thoracic and mediastinal disorders: Very rare: nasal dryness
Very rare: Bleeding of the lower gastrointestinal tract.
Skin and subcutaneous tissue disorders: Rare: acne, rash pruritic Very rare: urticaria
Hepatobiliary disorders: Rare: hepatic disorders
Rare: acne, rash pruritic
Very rare: urticaria
General disorders and administration site conditions: Rare: Ill-defined disorders.
Very rare: Increased number of white blood cells, increased blood lactate dehydrogenase.
Moderate elevation of transaminases has been reported in patients with hypertriglyceridemia.

What FARLIPID contains:
The active substance is omega-3 fatty acids. Oral Emulsion is at a bottle containing 300ml.
Excipients: Saccharin sodium, flavour banana, acacia, Water purified, Lemon flavour, Citral natural, Propylparaben sodium, Ethylparahydroxy benzoate sodium salt E215, Citric acid 50% (w/w)solution,propylparaben E216, Purity gum 1773.